TH34

CAS No. 2196203-96-8

TH34 ( —— )

Catalog No. M20117 CAS No. 2196203-96-8

TH34 is an HDAC6/8/10 inhibitor (IC50s: 4.6/1.9/7.7 μM). It shows high selectivity over HDAC1/2/3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 In Stock
10MG 115 In Stock
25MG 245 In Stock
50MG 394 In Stock
100MG 537 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TH34
  • Note
    Research use only not for human use.
  • Brief Description
    TH34 is an HDAC6/8/10 inhibitor (IC50s: 4.6/1.9/7.7 μM). It shows high selectivity over HDAC1/2/3.
  • Description
    TH34 is an HDAC6/8/10 inhibitor (IC50s: 4.6/1.9/7.7 μM). It shows high selectivity over HDAC1/2/3.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC6; HDAC8; HDAC10
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2196203-96-8
  • Formula Weight
    256.3
  • Molecular Formula
    C15H16N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 80 mg/mL (312.13 mM);Water: Insoluble
  • SMILES
    Cc1ccc(cc1NCc1ccccc1)C(=O)NO
  • Chemical Name
    3-(benzylamino)-N-hydroxy-4-methylbenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kolbinger FR et al. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines. Arch Toxicol. 2018 Aug;92(8):2649-2664.
molnova catalog
related products
  • RTS-V5

    RTS-V5 (Dual HDAC-proteasome inhibitor RTS-V5) is the first-in-class, dual HDAC-proteasome inhibitor.

  • GSK-3117391

    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.

  • AES-350

    AES-350 is a potent and orally active HDAC6 inhibitor(IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively).